Virtual Medicinal Product (VMP)
-
Testosterone 2% transdermal gel (10mg per actuation)
Name Details
Current Name
Testosterone 2% transdermal gel (10mg per actuation)
|
Start Date
01-11-2023
|
End Date
|
Previous Name
Testosterone 2% gel (10mg per actuation)
|
Start Date
30-07-2015
|
End Date
31-10-2023
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.5
- UDFS UOM
- gram
- Unit Dose UOM
- actuation
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 4 (CD Anab)
- Route
- Transdermal
- Form
- Transdermal gel
- Ontology Form/Route
- gel.transdermal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G03BA03
BNF |
Current BNF
06040200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06040200
|
Start Date
09-05-2008
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
11564011000001106 |
18-06-2007 |
|
VMP Ingredients
VMP ingredients table
Testosterone |
Based on Ingredient Substance |
|
20 mg |
1 gram |
Name
Testosterone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Testosterone
-
VMP
(Current) Testosterone 2% transdermal gel (10m...
Virtual Medicinal Product Pack (VMPP) Information